Shanghai MicroPort EP MedTech Co., Ltd. (SHA:688351)
China
· Delayed Price · Currency is CNY 22.62
+1.71 (8.18%)
At close: Apr 22, 2025, 2:57 PM CST
SHA:688351 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 406.88 | 319.99 | 257.52 | 189.41 | 140.26 | Upgrade
|
| Other Revenue | 6.28 | 9.21 | 2.81 | 0.62 | 1.03 | Upgrade
|
| Revenue | 413.17 | 329.19 | 260.32 | 190.03 | 141.29 | Upgrade
|
| Revenue Growth (YoY) | 25.51% | 26.46% | 36.99% | 34.50% | 20.31% | Upgrade
|
| Cost of Revenue | 173.49 | 120.66 | 81.13 | 53.09 | 39.19 | Upgrade
|
| Gross Profit | 239.68 | 208.54 | 179.19 | 136.94 | 102.1 | Upgrade
|
| Selling, General & Admin | 153.5 | 150.15 | 117.19 | 104.61 | 70.58 | Upgrade
|
| Research & Development | 77.4 | 91.31 | 76.93 | 63.01 | 39.83 | Upgrade
|
| Other Operating Expenses | -23.63 | -13.63 | 1.26 | 0.97 | 0.6 | Upgrade
|
| Operating Expenses | 208.54 | 229.18 | 196.19 | 168.8 | 111.26 | Upgrade
|
| Operating Income | 31.13 | -20.64 | -16.99 | -31.86 | -9.16 | Upgrade
|
| Interest Expense | -0.89 | -1.27 | -0.72 | -0.46 | - | Upgrade
|
| Interest & Investment Income | 13.09 | 16.97 | 9.32 | 7.66 | 3.22 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.02 | -0.56 | -1.21 | -0.23 | -0.49 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.23 | 0.96 | 2.25 | -0.14 | -0.1 | Upgrade
|
| EBT Excluding Unusual Items | 43.13 | -4.54 | -7.35 | -25.02 | -6.52 | Upgrade
|
| Gain (Loss) on Sale of Investments | 11.43 | 12.19 | 1.08 | -2.88 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.03 | - | 0.02 | - | - | Upgrade
|
| Asset Writedown | -0.08 | -0.04 | -0.08 | -0.12 | -0.03 | Upgrade
|
| Other Unusual Items | -2.32 | -2 | 9.3 | 16.05 | 12.29 | Upgrade
|
| Pretax Income | 52.13 | 5.61 | 2.97 | -11.97 | 5.74 | Upgrade
|
| Income Tax Expense | 0.06 | -0.08 | -0.1 | - | - | Upgrade
|
| Net Income | 52.07 | 5.69 | 3.07 | -11.97 | 5.74 | Upgrade
|
| Net Income to Common | 52.07 | 5.69 | 3.07 | -11.97 | 5.74 | Upgrade
|
| Net Income Growth | 815.36% | 85.17% | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 471 | 470 | 421 | 400 | 383 | Upgrade
|
| Shares Outstanding (Diluted) | 471 | 470 | 421 | 400 | 383 | Upgrade
|
| Shares Change (YoY) | 0.14% | 11.71% | 5.08% | 4.62% | 7.28% | Upgrade
|
| EPS (Basic) | 0.11 | 0.01 | 0.01 | -0.03 | 0.01 | Upgrade
|
| EPS (Diluted) | 0.11 | 0.01 | 0.01 | -0.03 | 0.01 | Upgrade
|
| EPS Growth | 814.05% | 65.75% | - | - | - | Upgrade
|
| Free Cash Flow | 23.52 | -79.9 | -41.31 | -16.02 | -22.48 | Upgrade
|
| Free Cash Flow Per Share | 0.05 | -0.17 | -0.10 | -0.04 | -0.06 | Upgrade
|
| Gross Margin | 58.01% | 63.35% | 68.83% | 72.06% | 72.27% | Upgrade
|
| Operating Margin | 7.54% | -6.27% | -6.53% | -16.77% | -6.48% | Upgrade
|
| Profit Margin | 12.60% | 1.73% | 1.18% | -6.30% | 4.06% | Upgrade
|
| Free Cash Flow Margin | 5.69% | -24.27% | -15.87% | -8.43% | -15.91% | Upgrade
|
| EBITDA | 58.7 | 0.61 | -3.68 | -21.05 | 0.3 | Upgrade
|
| EBITDA Margin | 14.21% | 0.19% | -1.41% | -11.07% | 0.22% | Upgrade
|
| D&A For EBITDA | 27.57 | 21.26 | 13.31 | 10.82 | 9.46 | Upgrade
|
| EBIT | 31.13 | -20.64 | -16.99 | -31.86 | -9.16 | Upgrade
|
| EBIT Margin | 7.54% | -6.27% | -6.53% | -16.77% | -6.48% | Upgrade
|
| Effective Tax Rate | 0.11% | - | - | - | - | Upgrade
|
| Revenue as Reported | 413.17 | 329.19 | 260.32 | 190.03 | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.